GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $271,000 | -13.7% | 5,767 | -21.7% | 0.14% | -16.3% |
Q3 2019 | $314,000 | -9.0% | 7,367 | -14.6% | 0.17% | +3.1% |
Q2 2019 | $345,000 | -22.5% | 8,629 | -18.9% | 0.16% | -26.8% |
Q1 2019 | $445,000 | +17.7% | 10,637 | +7.6% | 0.22% | +4.8% |
Q4 2018 | $378,000 | +10.9% | 9,883 | +16.8% | 0.21% | +5.5% |
Q2 2018 | $341,000 | -15.8% | 8,460 | -18.4% | 0.20% | -15.0% |
Q1 2018 | $405,000 | -8.2% | 10,372 | -16.6% | 0.23% | -19.3% |
Q4 2017 | $441,000 | -15.5% | 12,430 | -3.3% | 0.29% | -16.9% |
Q3 2017 | $522,000 | +63.6% | 12,851 | +73.8% | 0.35% | +60.8% |
Q2 2017 | $319,000 | -9.1% | 7,395 | -11.1% | 0.22% | -9.2% |
Q1 2017 | $351,000 | -32.1% | 8,316 | -38.0% | 0.24% | -35.8% |
Q4 2016 | $517,000 | +56.7% | 13,416 | +75.5% | 0.37% | +58.3% |
Q3 2016 | $330,000 | +0.9% | 7,644 | +1.4% | 0.24% | +2.6% |
Q2 2016 | $327,000 | -28.1% | 7,541 | -32.8% | 0.23% | -30.4% |
Q1 2016 | $455,000 | +64.9% | 11,220 | +64.2% | 0.33% | +46.9% |
Q4 2015 | $276,000 | – | 6,833 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 5,993,336 | $264,217,000 | 32.64% |
Black Creek Investment Management Inc. | 10,373,943 | $457,491,000 | 12.20% |
KAHN BROTHERS GROUP INC | 1,438,569 | $63,440,893,000 | 8.71% |
EQUITY INVESTMENT CORP | 2,932,078 | $129,305,000 | 4.68% |
JET CAPITAL INVESTORS L P | 400,000 | $17,640,000 | 4.67% |
Eversept Partners, LP | 1,503,700 | $66,313,170 | 4.24% |
NKCFO LLC | 269,500 | $11,885,000 | 3.82% |
Camber Capital Management LP | 2,500,000 | $110,250,000 | 3.79% |
CLIFFORD CAPITAL PARTNERS LLC | 113,866 | $5,021,000 | 3.75% |
Robinson Value Management, Ltd. | 97,677 | $4,308,000 | 3.54% |